Key Highlights Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity treatment, sold under Ozempic®, Wegovy®, and Rybelsus®.…
Category:
Brazil
-
Active Pharmaceutical Ingredients (API)BrazilEuropeEurope Medicine Agency (EMA)Global MarketIndiaIntellectual Property (IP)JapanLaunchPatent LitigationPharma Science & ResearchRegulatoryU.S FDAUSA
-
BrazilSipcam Nichino
Sipcam Nichino Launches Tiofanil®FS (Chlorothalonil+Thiophanate-Methyl) Fungicide for Peanuts in Brazil
by adminby adminSipcam Nichino recently launched Tiofanil®FS, a peanut fungicide with Chlorothalonil + Thiophanate-Methyl, in Brazil. Tiofanil®FS is an internal, contact, broad-spectrum fungicide formulated…
-
AdamaBrazilCombination ProductsGlobal MarketLaunch
ADAMA Launches Combination Herbicide Apresa (flumioxazine + S-metolachlor) in Brazil
by adminby adminSummary : Apresa, a premium pre-emergent herbicide for various crops with an exclusive combination of active chemicals (Flumioxazin + S-metolachlor), was introduced…
-
BrazilPatents
INPI Publishes an Update on the Terms of Patent Protection for Pharmaceutical and Non-Pharmaceutical Claims.
by adminby adminSummary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…
